Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$28.47 USD
+0.38 (1.35%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $28.47 0.00 (0.00%) 7:56 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CSTL 28.47 +0.38(1.35%)
Will CSTL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CSTL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSTL
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Beat Estimates
Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
CSTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Castle Biosciences, Inc. (CSTL) Report Negative Earnings Next Week? What You Should Know
Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion
5 Top Small Cap Stocks to Buy Now
Other News for CSTL
BTIG life sciences/diagnostics analyst holds an analyst/industry conference call
BTIG life sciences/diagnostics analyst holds an analyst/industry conference call
New Data at ASTRO 2024 Shows Castle Biosciences? DecisionDx?-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma
The Melanoma Research Foundation to host the Los Angeles Miles for Melanoma 5K
BTIG life sciences/diagnostics analyst holds an analyst/industry conference call